Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)
Class II- Recalling firm
- Foundation Medicine, Inc.
- Reason for recall
- Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants
- Distribution pattern
- US Nationwide distribution in the states of Massachusetts and North Carolina.
- State
- MA
- Status
- Ongoing
- Recall number
- Z-1927-2026
- Recall initiated
- March 20, 2026